XOMA 052: Preliminary pilot trial data

Preliminary data from an open-label pilot trial in 4 patients who developed a posterior/panuveitis or retinal vasculitis attack showed that a single IV infusion of 0.3 mg/kg XOMA 052 resolved intraocu...